Alvotech ALVO

NAS: ALVO | ISIN: LU2458332611 17/02/2026

4,640 USD (0,00%)

(0,00%) 17/02/2026

Grafiek Alvotech

Grafiek Alvotech

1 dag1d 0,00%
1 week1w -4,33%
1 maand1m -6,45%
3 maanden3m -9,20%
6 maanden6m -48,44%
1 jaar1j -63,12%
5 jaar5j -58,53%

Alvotech in het nieuws

Toon enkel gratis nieuws

11 februari 2026 · Alvotech Announces Increase in Number of Own Shares · Persbericht

5 februari 2026 · Alvotech Announces Positive Top-Line Results from Pivotal Pharmacokinetic Study for Proposed Biosimilar to Entyvio® · Persbericht

2 februari 2026 · Alvotech enters supply and commercialization agreements for Canada and Australia & New Zealand covering multiple biosimilar candidates · Persbericht

29 januari 2026 · Alvotech Secures Settlement Agreement in Global Markets for its Biosimilar to Eylea® 2mg · Persbericht

7 januari 2026 · Correction: Transactions of Managers and Closely Associated Persons · Persbericht

6 januari 2026 · Transactions of Managers and Closely Associated Persons · Persbericht

6 januari 2026 · Alvotech announces planned CEO succession and leadership transition · Persbericht

31 december 2025 · Alvotech Secures Term Loan Facility of USD 100 Million · Persbericht

29 december 2025 · Changes in company's own shares · Persbericht

22 december 2025 · Alvotech’s Financial Calendar for 2026 · Persbericht

Mijn selecties

Je selectie is nog leeg.

Voeg nu effecten toe